Delcath Systems, Inc.

NasdaqCM:DCTH Stock Report

Market Cap: US$223.1m

Delcath Systems Past Earnings Performance

Past criteria checks 0/6

Delcath Systems's earnings have been declining at an average annual rate of -18.5%, while the Medical Equipment industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 11.4% per year.

Key information

-18.5%

Earnings growth rate

84.5%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate11.4%
Return on equity-340.6%
Net Margin-1,080.7%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Is Delcath Systems (NASDAQ:DCTH) Using Debt In A Risky Way?

Jan 15
Is Delcath Systems (NASDAQ:DCTH) Using Debt In A Risky Way?

Delcath Systems (NASDAQ:DCTH) Has Debt But No Earnings; Should You Worry?

Oct 04
Delcath Systems (NASDAQ:DCTH) Has Debt But No Earnings; Should You Worry?

Delcath Systems Q2 2022 Earnings Preview

Aug 05

Delcath Systems to raise $5M in stock and warrants offering

Jul 18

Delcath Systems: Revisiting A $5 Lottery Ticket

May 17

Is Delcath Systems (NASDAQ:DCTH) Weighed On By Its Debt Load?

Mar 24
Is Delcath Systems (NASDAQ:DCTH) Weighed On By Its Debt Load?

Does Delcath Systems (NASDAQ:DCTH) Have A Healthy Balance Sheet?

Nov 17
Does Delcath Systems (NASDAQ:DCTH) Have A Healthy Balance Sheet?

Diving Into Delcath Systems

Aug 09

Delcath Systems: Ready To Return To A Previous Winner

Jun 22

Delcath Systems set to join Russell Microcap Index

Jun 08

Is Delcath Systems (NASDAQ:DCTH) Using Debt In A Risky Way?

May 03
Is Delcath Systems (NASDAQ:DCTH) Using Debt In A Risky Way?

Revenue & Expenses Breakdown

How Delcath Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:DCTH Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 245-502717
31 Dec 232-482218
30 Sep 232-451917
30 Jun 233-341817
31 Mar 233-371719
31 Dec 223-371719
30 Sep 224-331618
30 Jun 224-321617
31 Mar 224-281515
31 Dec 214-261414
30 Sep 212-271513
30 Jun 212-251313
31 Mar 212-231212
31 Dec 202-241111
30 Sep 202-5811
30 Jun 202-71010
31 Mar 202-9109
31 Dec 192-9109
30 Sep 192-321213
30 Jun 193-341015
31 Mar 193-341017
31 Dec 183-191020
30 Sep 183-28917
30 Jun 183-321015
31 Mar 183-271014
31 Dec 173-461010
30 Sep 173-341010
30 Jun 172-231010
31 Mar 172-2799
31 Dec 162-1898
30 Sep 162-1598
30 Jun 162-1697
31 Mar 162-1397
31 Dec 152-15106
30 Sep 152-13115
30 Jun 151-15124
31 Mar 151-16134
31 Dec 141-17144
30 Sep 141-19176
30 Jun 141-22167
31 Mar 141-231810
31 Dec 131-302113
30 Sep 131-362116
30 Jun 131-412619

Quality Earnings: DCTH is currently unprofitable.

Growing Profit Margin: DCTH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DCTH is unprofitable, and losses have increased over the past 5 years at a rate of 18.5% per year.

Accelerating Growth: Unable to compare DCTH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DCTH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).


Return on Equity

High ROE: DCTH has a negative Return on Equity (-340.55%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.